IP Library Granted Patent US 7,608,663
Granted Patent B2
US 7,608,663 · App. 11/040,142 · Granted Oct 27, 2009

Method of preparing propionic acid-terminated polymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,608,663
App. No.
11/040,142
Granted
Oct 27, 2009
Kind
B2
Abstract

The invention provides methods for preparing polymers bearing a terminal propionic acid. The method involves first reacting a water soluble and non-peptidic polymer comprising at least one hydroxyl group with a tertiary alkyl acrylate in the presence of a catalyst to form a propionic acid ester of the polymer, wherein the polymer has a weight average molecular weight of at least about 10,000 Da; and then treating the propionic acid ester of the polymer with a strong acid to form a propionic acid of the polymer.

Claims (37)

1. A method for preparing a water soluble and non-peptidic polymer functionalized with at least one propionic acid group, the method comprising:

i) reacting a water soluble and non-peptidic polymer comprising at least one hydroxyl group with a tertiary alkyl acrylate in the presence of a catalyst comprising a quaternary ammonium salt to form a propionic acid ester of the polymer, wherein the polymer has a weight average molecular weight of at least about 10,000 Da; and

ii) treating the propionic acid ester of the polymer with a strong acid to form a propionic acid-functionalized polymer;

with the proviso that the water soluble and non-peptidic polymer functionalized with at least one propionic acid group is neither methoxy PEG propionic acid having a weight average molecular weight of about 20,000 Da, nor methoxy PEG propionic acid having a weight average molecular weight of about 30,000 Da.

2. The method of claim 1 , wherein the tertiary alkyl acrylate is α- or β-substituted.

3. The method of claim 2 , wherein the substituting group is selected from the group consisting of halo, hydroxyl, thiol, alkylthio, acyl, acyloxy, nitro, cyano, azido, trihalomethyl, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, and substituted heteroaryl.

4. The method of claim 3 , wherein the substituting group is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, and benzyl.

5. The method of claim 1 , wherein the tertiary alkyl group of the tertiary alkyl acrylate is tert-butyl, tert-amyl, α,α′-dimethylbenzyl, trityl, 1-adamantyl, or 2-methyl-2-adamantyl.

6. The method of claim 1 , wherein the tertiary alkyl acrylate has the structure:

wherein:

R 1 and R 2 are each independently selected from the group consisting of hydrogen, halo, hydroxyl, thiol, alkylthio, acyl, acyloxy, nitro, cyano, azido, trihalomethyl, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, and substituted heteroaryl; and

R 3 -R 5 are each independently alkyl, substituted alkyl, aryl or substituted aryl.

7. The method of claim 6 , wherein R 3 , R 4 , and R 5 , are each methyl, ethyl, or phenyl.

8. The method of claim 6 , wherein R 1 and R 2 are hydrogen.

9. The method of claim 6 , wherein R 1 is hydrogen and R 2 is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, and benzyl.

10. The method of claim 1 , wherein the strong acid is trifluoroacetic acid, trifluoromethanesulfonic acid, formic acid, hydrochloric acid, or toluenesulfonic acid.

11. The method of claim 1 , wherein the catalyst comprising the quaternary ammonium salt is selected from the group consisting of tetramethyl ammonium halide, tetraethyl ammonium halide, tetrapropyl ammonium halide, tetrabutyl ammonium halide, tetramethyl ammonium hydroxide, tetraethyl ammonium hydroxide, tetrapropyl ammonium hydroxide, and tetrabutyl ammonium hydroxide.

12. The method of claim 1 , wherein the catalyst comprising the quaternary ammonium salt has the structure:

wherein each R is independently alkyl or substituted alkyl and X is a counter ion.

13. The method of claim 12 , wherein each R is C1-C8 alkyl and X is halo or hydroxide.

14. The method of claim 1 , wherein said reacting step and said treating step are conducted in the presence of an organic solvent.

15. The method of claim 14 , wherein the organic solvent is selected from the group consisting of dichloromethane, tetrahydrofuran, dimethylformamide, acetonitrile, toluene, xylene, phenylacetonitrile, nitrobenzene, tetrachloroethylene, anisole, and chlorobenzene.

16. The method of claim 1 , wherein the polymer has a weight average molecular weight of about 10,000 to about 100,000 Da.

17. The method of claim 16 , wherein the polymer has a weight average molecular weight of about 20,000 to about 60,000 Da.

18. The method of claim 1 , wherein the water soluble and non-peptidic polymer is selected from the group consisting of poly(alkylene glycols), poly(olefinic alcohol), poly(vinylpyrrolidone), poly(hydroxyalkylmethacrylamide), poly(hydroxyalkylmethacrylate), poly(saccharides), poly(α-hydroxyacetic acid), poly(acrylic acid), poly(vinyl alcohol), polyphosphazene, polyoxazolines, poly(N-acryloylmorpholine), and copolymers or terpolymers thereof.

19. The method of claim 1 , wherein the water soluble and non-peptidic polymer is poly(ethylene glycol).

20. The method of claim 19 , wherein the poly(ethylene glycol) is selected from the group consisting of monofunctional PEG, difunctional PEG, and branched PEG.

21. The method of claim 19 , wherein the poly(ethylene glycol) has a weight average molecular weight of about 10,000 to about 100,000 Da.

22. The method of claim 21 , wherein the poly(ethylene glycol) has a weight average molecular weight of about 20,000 to about 60,000 Da.

23. The method of any one of claims 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 and 22 , further comprising the step of chromatographically purifying the propionic acid of the polymer to separate the propionic acid of the polymer from impurities bearing a hydroxyl end-cap.

24. The method of claim 23 , further comprising derivatizing the propionic acid-functionalized polymer to form a reactive derivative.

25. The method of claim 1 , further comprising derivatizing the propionic acid-functionalized polymer to form an acid derivative selected from the group consisting of acyl halide, acyl pseudohalide, ester, anhydride, amide, imide, and hydrazide.

26. The method of claim 1 , further comprising derivatizing the propionic acid-functionalized polymer to form an active ester.

27. The method of claim 26 , wherein the active ester is selected from the group consisting of N-succinimidyl ester, o-, m-, or p-nitrophenyl ester, 1-benzotriazolyl ester, imidazolyl ester, and N-sulfosuccinimidyl ester.

28. A method for preparing a branched water soluble and non-peptidic polymer functionalized with at least one propionic acid group, the method comprising:

i) reacting a branched water soluble and non-peptidic polymer comprising at least one hydroxyl group with a tertiary alkyl acrylate in the presence of a catalyst to form a propionic acid ester of the polymer, wherein the polymer has a weight average molecular weight of at least about 10,000 Da; and

ii) treating the propionic acid ester of the polymer with a strong acid to form a propionic acid of the polymer.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2006
From: KOZLOWSKI, ANTONI; MCMANUS, SAMUEL P.
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 018034/0800 →